Free Trial
OTCMKTS:MLLCF

Molecular Partners (MLLCF) Stock Price, News & Analysis

Molecular Partners logo
$4.22 0.00 (0.00%)
As of 05/2/2025

About Molecular Partners Stock (OTCMKTS:MLLCF)

Key Stats

Today's Range
$4.22
$4.22
50-Day Range
$4.22
$4.22
52-Week Range
$3.66
$10.14
Volume
N/A
Average Volume
525 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317 which is in Phase I clinical trials, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.

Receive MLLCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter.

MLLCF Stock News Headlines

Using advances in AI to combat illegal timber trade
Molecular Partners to Boost Finances with Share Sale
Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
Molecular Partners (MOLN) Gets a Buy from Leerink Partners
Molecular Partners expands 212Pb co-development agreement with Orano Med
See More Headlines

MLLCF Stock Analysis - Frequently Asked Questions

Molecular Partners' stock was trading at $4.11 at the beginning of 2025. Since then, MLLCF stock has increased by 2.7% and is now trading at $4.22.
View the best growth stocks for 2025 here
.

Shares of MLLCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:MLLCF
CIK
N/A
Fax
N/A
Employees
167
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:MLLCF) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners